Tonix Pharmaceuticals Holding (TNXP) Return on Assets Growth (3y) (2014 - 2026)

Tonix Pharmaceuticals Holding (TNXP) Return on Assets Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,079.99 Bn 66,079.71 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 471.68 Bn 466.89 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.31 Bn 115.06 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.24 Bn 61.49 Bn 3.31 Bn
7 Belite Bio 63.01 Bn 63.01 Bn -
8 Argenx Se 56.02 Bn 50.83 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.46 Bn 34.45 Bn 959.66 Mn
10 Tonix Pharmaceuticals Holding 142.28 Mn 142.28 Mn 5.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 -1.00
Sep 30, 2024 -1.00
Jun 30, 2024 -1.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 1.00
Dec 31, 2022 2.00
Sep 30, 2022 2.00
Jun 30, 2022 1.00
Mar 31, 2022 1.00
Dec 31, 2021 1.00
Sep 30, 2021 1.00
Dec 31, 2020 0.00